OpenTender (EU)
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zu Fertigarzneimitteln mit dem Wirkstoff Cladribin
GWQ ServicePlus AG
Awarded
EU
supplies
This tender has closed
The submission deadline for this contract has passed. There may be more active supplies tenders from GWQ ServicePlus AG, and hundreds more across the UK public sector.
Key details
Contracting authority
GWQ ServicePlus AG
other
Region
Germany
Sector
Contract value
Not stated by buyer
Submissions closed
Not stated by buyer
Published
24 December 2021
Procurement
Procedure type
pt_award_contract_without_call
CPV classifications
- 33600000 Pharmaceutical products
What happened
GWQ ServicePlus AG awarded this contract to Merck Serono GmbH on 24 Dec 2021.
Description
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Produkt Mavenclad(R) Vertragsstart: 01.01.2022 Vertragsende: 31.12.2023
Awarded supplier
Supplier
Merck Serono GmbH
Award date
24 December 2021
Bidders
1 bidder
Contact
Identifiers
Buyer reference
2021/S 250-661442
Notice ID
ocds-70d2nz-9fac1b9c-6ea5-45db-8ecd-712a90835498-2021-12-24T00:00:00.000Z
OCID
ocds-70d2nz-9fac1b9c-6ea5-45db-8ecd-712a90835498
Explore related tenders
External ID: ot-ocds-70d2nz-9fac1b9c-6ea5-45db-8ecd-712a90835498 • Added 12 May 2026